Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Allied Healthcare Products

This article was originally published in The Gray Sheet

Executive Summary

Completes acquisition of Toledo, Ohio-based B&F Medical Products for 640,000 shares of Allied common stock and an estimated $11.7 mil. in cash, "subject to certain adjustments," Allied announces. On Sept. 2, the last trading day before the announcement, Allied stock closed at $16 per share, making the total deal worth about $22 mil. B&F Medical manufactures plastic disposable medical products primarily for the home health care market. The company had net sales of approximately $23 mil. for the fiscal year ended April 30, with income from operations of $2.5 mil. St. Louis-based Allied, a manufacturer of medical gas equipment and respiratory therapy products, had net sales of $74.1 mil. for its fiscal year ending June 30 and net income of $7.3 mil

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002785

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel